Shafei Wu
Impact in
- Oncology top 10%
- Lung Cancer Research Studies
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
- Cancer Research top 10%
- Cancer Genomics and Diagnostics
Papers in
- Oncology 35
- HER2/EGFR in Cancer Research 12
- Lung Cancer Research Studies 12
- Pancreatic and Hepatic Oncology Research 5
-
- Cancer Genomics and Diagnostics 5
- Breast Cancer Treatment Studies 5
- Co-authors
- Xuan ZengZhiyong LiangXiaohua ShiYufeng LuoJie GaoTonghua LiuJing ZhangJian Sun
- Journals
- Diagnostic Pathology (3 papers)Journal of Gastroenterology and Hepatology (2 papers)BMC Cancer (2 papers)Human Pathology (2 papers)Frontiers in Oncology (2 papers)
- Partner nations
- ChinaUnited States
In The Last Decade
Shafei Wu
58 papers receiving 703 citations
Peers
Comparison fields: 5 of 55
- Oncology 440
- Cancer Research 165
- Pulmonary and Respiratory Medicine 338
- Pathology and Forensic Medicine 102
- Surgery 162
Countries citing papers authored by Shafei Wu
This map shows the geographic impact of Shafei Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shafei Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shafei Wu more than expected).
Fields of papers citing papers by Shafei Wu
This network shows the impact of papers produced by Shafei Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shafei Wu. The network helps show where Shafei Wu may publish in the future.
Co-authors
The 25 scholars most cited alongside Shafei Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 9 | |
| 4 | 2023 | 3 | |
| 5 | 2021 | 24 | |
| 6 | 2020 | 17 | |
| 7 | 2020 | 11 | |
| 8 | 2020 | 8 | |
| 9 | 2020 | 15 | |
| 10 | 2019 | 5 | |
| 11 | 2018 | 2 | |
| 12 | 2018 | 8 | |
| 13 | 2017 | 38 | |
| 14 | [HER2 mRNA expression in breast cancers with equivocal immunohistochemical results using in situ mRNA hybridization]. | 2015 | 1 |
| 15 | 2014 | 9 | |
| 16 | [Protein overexpression and gene copy number of EGFR and HER2 in colorectal carcinoma]. | 2007 | 2 |
| 17 | 2007 | 6 | |
| 18 | [Analysis of HER2 gene status in breast cancer with HER2 protein overexpression]. | 2006 | 2 |
| 19 | [Evaluation of HER2 gene expression status in breast cancer by fluorescence in-situ hybridization]. | 2005 | 5 |
| 20 | 2004 | 20 |
About Shafei Wu
Shafei Wu is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Transplantation and Pathology and Forensic Medicine, having authored 59 papers that have together received 720 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (24 papers), HER2/EGFR in Cancer Research (12 papers), Lung Cancer Research Studies (12 papers), Lung Cancer Diagnosis and Treatment (6 papers), Pancreatic and Hepatic Oncology Research (5 papers), Cancer Genomics and Diagnostics (5 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Breast Cancer Treatment Studies (5 papers). The work is most often cited by research in Oncology (440 citations), Cancer Research (165 citations), Pulmonary and Respiratory Medicine (338 citations), Pathology and Forensic Medicine (102 citations) and Surgery (162 citations). Shafei Wu has collaborated with scholars based in China and United States. Frequent co-authors include Xuan Zeng, Zhiyong Liang, Xiaohua Shi, Yufeng Luo, Jie Gao, Tonghua Liu, Jing Zhang, Jian Sun, Yuanyuan Liu and Yuanyuan Liu. Their work appears in journals such as Diagnostic Pathology, Journal of Gastroenterology and Hepatology, BMC Cancer, Human Pathology and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.